New Technology for Deep Light Distribution in Tissue for Phototherapy

@article{Chen2002NewTF,
  title={New Technology for Deep Light Distribution in Tissue for Phototherapy},
  author={James C. Chen and Llew Keltner and J. S. Christophersen and F C Zheng and Mike Krouse and Anil Kumar Singhal and Sy-shi Wang},
  journal={The Cancer Journal},
  year={2002},
  volume={8},
  pages={154–163}
}
Photodynamic therapy is one of several techniques developed for phototherapy for solid cancers and hematologic malignancies. Photodynamic therapy is a treatment that utilizes a molecular energy exchange between visible light and a photosensitive drug, which results in the production of 1O2, a highly reactive cytocidal oxygen species. The effect is limited to the region where light and drug are combined so that malignant tissue is destroyed and the usual side effects associated with standard… 

ART AND SCIENCE OF PHOTODYNAMIC THERAPY

TLDR
The aim of the present review was to provide a general overview of the art and science of photodynamic therapy and to highlight some of the issues and recent developments in further advancing this modality of treatment.

Photodynamic therapy: oncologic horizons.

TLDR
Current research and outcomes from the basic science and clinical applications of oncologic PDT are highlighted and how these findings may lead to enhanced and refined future PDT is interpreted.

Current Status of Photodynamic Therapy for Renal Tumors

TLDR
The majority of this chapter will focus on the science of PDT, some of the photosensitizers available, promising technologies on the horizon, and some preclinical data on treatment of renal tissue.

Photodynamic therapy: oncologic

TLDR
Current research and outcomes from the basic science and clinical applications of oncologic PDT are highlighted and how these findings may lead to enhanced and refined future PDT is interpreted.

Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges

TLDR
This review will discuss the recent progress and technical challenges of various forms of interstitial PDT for the treatment of parenchymal and/or stromal tissues of solid tumors.

Light Sources and Dosimetry Techniques for Photodynamic Therapy

TLDR
The basic physics of light sources are summarized, methods for determining the dose delivered to the patient are described, and the selection of light source and delivery device appropriate to the target tissue are described.

Interstitial photodynamic laser therapy in interventional oncology

TLDR
After intravenous treatment with the photosensitizer followed by interstitial light activation, contrast-enhanced computed tomography shows the development of therapy-induced necrosis around the light-guiding device.

Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.

Light Sources, Drugs, and Dosimetry

This chapter will address the technical and physical aspects of the light sources, delivery devices, and photosensitizers used in ENT photodynamic therapy (PDT). Effective delivery of treatment light
...

References

SHOWING 1-10 OF 56 REFERENCES

Photodynamic therapy: the clinical perspective. Review on applications for control of diverse tumorous and non-tumorous diseases.

TLDR
The current review article discusses in some more detail the treatment of endobronchial lung cancer, one of the leading indications of PDT, and a broad overview is given on the use of PDT for treatment of a wide variety of tumorous and nontumorous diseases, including new strategies for control of rheumatoid arthritis and application for extracorporeal bone marrow purging.

Current concepts in gastrointestinal photodynamic therapy.

TLDR
D PDT has a potentially important role either as a primary or adjuvant mode of treatment of tumors of the gastrointestinal tract and many issues regarding pharmacokinetic data of photosensitizers, newer technology involved in light sources, optimal treatment regimens that take advantage of the pharmacophysiology of photoablation, and light dosimetry still require solution.

Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.

TLDR
PDT treatment of a human sarcoma xenograft in nude mice is evaluated and the mechanism of PDT-mediated antitumor effect appears to be vascular damage with initial apoptosis in tumor endothelial cells and delayed tumor cell apoptosis.

In situ COMPARISON OF 665 nm and 633 nm WAVELENGTH LIGHT PENETRATION IN THE HUMAN PROSTATE GLAND

TLDR
The enhanced light fluence and penetration depth with 665 nm light should allow significantly larger volumes of prostatic tissue to be treated with SnET2‐mediated PDT.

Photodynamic therapy for recurrent nasopharyngeal cancer.

TLDR
Long-term tumor control can be achieved by photodynamic therapy in cases where very high doses of ionizing radiation have failed, and the entire treatment can be accomplished in 30 minutes under topical anesthesia.

Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor.

TLDR
It has to be concluded that in the RIF tumor hypoxic tumor cells are inactivated by a mechanism other than direct photodynamic cytotoxicity, and are thus not limiting to PDT tumor response.

SITES OF PHOTODAMAGE in vivo and in vitro BY A CATIONIC PORPHYRIN

TLDR
Pharmacokinetic studies indicate that plasma levels, not tissue levels were the major determinant of photodynamic therapy (PDT) response, and vascular damage and disturbances of tissue perfusion following PDT were more pronounced in tumor‐bearing skin than in normal skin.

Photodynamic therapy for upper gastrointestinal tumours over the past 10 years.

TLDR
A total of 207 patients with advanced upper gastrointestinal tumors were treated with photodynamic therapy (PDT) from 1982 to 1992 and the effectiveness is reported and the follow-up survey of the results is evaluated.
...